CONTEXT: Duke University researchers have shown that a test assessing functional and morphologic information gathered during contrast-enhanced MRI renders a score that accurately predicts the response of nine of 10 breast cancer cases to neoadjuvant chemotherapy.
RESULTS: T1-weighted imaging was performed in 20 women with locally advanced breast cancer. Principal investigator Oana Craciunescu, Ph.D., an assistant clinical professor of radiation oncology at Duke, studied the characteristics of tumor perfusion, permeability, and morphology/cellularity. Highly vascular tumors with efficient vascular systems carried more tracer and chemotherapy than tumors fed by less efficient vessels. Homogeneous tumors with an even distribution of blood vessels responded best to therapy. Tumors with densely packed cancer cells did not effectively retain the tracer and responded poorly.
Tumors featuring an equatorial ring of blood vessels also tended to resist chemotherapy because of collapsed vessels.
IMAGE: Morphophysiological tumor scores based on a five-point scale were calculated for a responder (top) and a nonresponder (bottom) to chemotherapy performed before surgery. Enhancement curves revealed the tumor's washin (WiP), washout (WoP), and centripetal (CP) and centrifugal (CF) characteristics. WiP measured the mass's vascularity, permeability, and homogeneity. Tumors with an inhomogeneous pattern or ring enhancement were classified as CP. Tumors with a homogeneous pattern were classified as CF. WoP correlated with tumor cellularity.
IMPLICATIONS: Poor responders identified by this technique can be referred directly to surgery, thereby avoiding the discomfort of chemotherapy. The method will be tested at Duke in a larger trial of patients with locally advanced breast cancer.
Leading Breast Radiologists Discuss the USPSTF Breast Cancer Screening Recommendations
May 17th 2024In recognition of National Women’s Health Week, Dana Bonaminio, MD, Amy Patel, MD, and Stacy Smith-Foley, MD, shared their thoughts and perspectives on the recently updated breast cancer screening recommendations from the United States Preventive Services Task Force (USPSTF).
Multicenter CT Study Shows Benefits of Emerging Diagnostic Model for Clear Cell Renal Cell Carcinoma
May 15th 2024Combining clinical and CT features, adjunctive use of a classification and regression tree (CART) diagnostic model demonstrated AUCs for detecting clear cell renal cell carcinoma (ccRCC) that were 15 to 22 percent higher than unassisted radiologist assessments.
CT Study: AI Algorithm Comparable to Radiologists in Differentiating Small Renal Masses
May 14th 2024An emerging deep learning algorithm had a lower AUC and sensitivity than urological radiologists for differentiating between small renal masses on computed tomography (CT) scans but had a 21 percent higher sensitivity rate than non-urological radiologists, according to new research.